GBT - Global Blood Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $27.34. This is a potential upside of $27.34 (0%) from yesterday's end of day stock price of $0.

Global Blood Therapeutics's activity chart (see below) currently has 195 price targets and 129 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 51.63% with an average time for these price targets to be met of 344.72 days.

Most recent stock forecast was given by ANDREW BERENS from LEERINK on 09-Aug-2022. First documented stock forecast 08-Sep-2015.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Aug-2022

$68.5

$0.01 (0.01%)

3 years 6 months 15 days ago
(09-Aug-2022)

3/4 (75%)

$1.91 (2.87%)

313

Hold Since 09-Aug-2022

$68.5

$0.01 (0.01%)

$67

3 years 6 months 15 days ago
(09-Aug-2022)

7/9 (77.78%)

$1.91 (2.87%)

825

Hold Since 09-Aug-2022

$68.5

$0.01 (0.01%)

$133

3 years 6 months 15 days ago
(09-Aug-2022)

1/5 (20%)

$1.91 (2.87%)

567

Hold Since 08-Aug-2022

$71

3 years 6 months 16 days ago
(08-Aug-2022)

0/1 (0%)

$35.72 (101.25%)

Hold Since 08-Aug-2022

$60

$-8.49 (-12.40%)

3 years 6 months 16 days ago
(08-Aug-2022)

1/3 (33.33%)

$-6.6 (-9.91%)

276

Show more analysts

Please expand the browser size to see the chart

What is GBT (Global Blood Therapeutics) average time for price targets to be met?

On average it took 344.72 days on average for the stock forecasts to be realized with a an average price target met ratio 51.63

Which analyst has the current highest performing score on GBT (Global Blood Therapeutics) with a proven track record?

RITU BARAL

Which analyst has the most public recommendations on GBT (Global Blood Therapeutics)?

Ritu Baral works at TD COWEN and has 0 price targets and 0 ratings on GBT

Which analyst is the currently most bullish on GBT (Global Blood Therapeutics)?

Liana Moussatos with highest potential upside - $83.51

Which analyst is the currently most reserved on GBT (Global Blood Therapeutics)?

Tessa Romero with lowest potential downside - -$32.49

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?